ME00530B - Farmaceutske kompozicije tizoksanida i nitazoksanida - Google Patents

Farmaceutske kompozicije tizoksanida i nitazoksanida

Info

Publication number
ME00530B
ME00530B MEP-2008-877A MEP87708A ME00530B ME 00530 B ME00530 B ME 00530B ME P87708 A MEP87708 A ME P87708A ME 00530 B ME00530 B ME 00530B
Authority
ME
Montenegro
Prior art keywords
pharmaceutical compositions
tizoxanide
nitazoxanide
treatment
active agent
Prior art date
Application number
MEP-2008-877A
Other languages
English (en)
Inventor
Jean-Francais Rossignol
Original Assignee
Romark Labaratories L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00530(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Labaratories L C filed Critical Romark Labaratories L C
Publication of ME00530B publication Critical patent/ME00530B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmaceutska kompozicija koja kao aktivno sredstvo sadrži najmanje jedno jedinjenje koje je odabrano od grupa koje sadrže formule (I) ili (II). Aktivno sredstvo je po mogućstvu u obliku čestica koje imaju veličinu manju od 200 μm i srednju vrednost veličine čestice veću od 10 μm. Farmaceutske kompozicije su naročito korisne u lečenju oportunističkih infekcija kod osoba sa komprimovanim ili supresivnim imunim sistemima, i u u lečenju infekcija trematoda.
MEP-2008-877A 1997-05-07 1998-05-06 Farmaceutske kompozicije tizoksanida i nitazoksanida ME00530B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (1)

Publication Number Publication Date
ME00530B true ME00530B (me) 2011-10-10

Family

ID=27420362

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-877A ME00530B (me) 1997-05-07 1998-05-06 Farmaceutske kompozicije tizoksanida i nitazoksanida

Country Status (35)

Country Link
EP (2) EP1222921B1 (me)
JP (1) JP3739802B2 (me)
KR (2) KR100426657B1 (me)
CN (2) CN1158074C (me)
AP (1) AP1103A (me)
AR (1) AR057242A2 (me)
AT (2) ATE281166T1 (me)
AU (1) AU740022B2 (me)
BG (2) BG109365A (me)
BR (1) BR9808722A (me)
CA (2) CA2418634C (me)
CZ (2) CZ298269B6 (me)
DE (2) DE69827417T2 (me)
DK (2) DK1222921T3 (me)
EA (2) EA002920B1 (me)
EE (1) EE04870B1 (me)
ES (2) ES2232687T3 (me)
GE (1) GEP20032970B (me)
HK (1) HK1025907A1 (me)
HU (1) HU229641B1 (me)
IL (2) IL155799A (me)
IS (1) IS2087B (me)
LV (1) LV12492B (me)
ME (1) ME00530B (me)
NO (2) NO313983B1 (me)
NZ (2) NZ500149A (me)
OA (1) OA11169A (me)
PL (1) PL193275B1 (me)
PT (2) PT1222921E (me)
RO (1) RO120605B1 (me)
SI (1) SI20149B (me)
SK (2) SK283947B6 (me)
TR (1) TR199902733T2 (me)
UA (2) UA57079C2 (me)
WO (1) WO1998050035A1 (me)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
CA2636527C (en) 2006-01-09 2016-05-17 Romark Laboratories, L.C. Viral hepatitis treatment
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
PE20121118A1 (es) 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
EP2445349B1 (en) 2009-06-26 2022-02-09 Romark Laboratories, L.C. Compounds and methods for treating influenza
US9498441B2 (en) 2012-01-27 2016-11-22 Siegfried Rhein S.A. De C.V. Nitazoxadine composition and process to prepare same
AU2015346413B2 (en) * 2014-11-11 2019-08-29 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
EP4146664A2 (en) 2020-05-01 2023-03-15 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
KR20040004544A (ko) 2004-01-13
UA57079C2 (uk) 2003-06-16
AU740022B2 (en) 2001-10-25
KR100576646B1 (ko) 2006-05-08
NO335781B1 (no) 2015-02-16
HK1025907A1 (en) 2000-12-01
DE69809928T2 (de) 2003-04-24
SK283947B6 (sk) 2004-05-04
EP1005342A4 (en) 2001-02-07
UA74388C2 (uk) 2005-12-15
GEP20032970B (en) 2003-05-27
IL155799A (en) 2004-08-31
SI20149B (en) 2001-08-31
NO20021832L (no) 2000-01-04
AU7289598A (en) 1998-11-27
NO20021832D0 (no) 2002-04-18
BR9808722A (pt) 2000-07-11
CA2288003A1 (en) 1998-11-12
CZ298270B6 (cs) 2007-08-08
IL155799A0 (en) 2003-12-23
JP2001503067A (ja) 2001-03-06
CA2418634A1 (en) 1998-11-12
CZ391199A3 (cs) 2000-07-12
SK283946B6 (sk) 2004-05-04
EA199901012A1 (ru) 2000-08-28
OA11169A (en) 2003-04-25
KR100426657B1 (ko) 2004-04-13
DE69809928D1 (de) 2003-01-16
ES2150404T3 (es) 2003-07-01
CN1255060A (zh) 2000-05-31
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
CN1552322A (zh) 2004-12-08
NO995406D0 (no) 1999-11-04
CN100515420C (zh) 2009-07-22
NZ500149A (en) 2001-11-30
AP1103A (en) 2002-09-04
EP1222921A1 (en) 2002-07-17
EA002920B1 (ru) 2002-10-31
BG109365A (en) 2006-08-31
SI20149A (sl) 2000-08-31
BG64973B1 (bg) 2006-11-30
PT1005342E (pt) 2003-02-28
DE69827417D1 (de) 2004-12-09
PT1222921E (pt) 2005-02-28
DK1005342T3 (da) 2003-03-24
CZ298269B6 (cs) 2007-08-08
TR199902733T2 (xx) 2000-03-21
EP1222921B1 (en) 2004-11-03
SK151199A3 (en) 2000-07-11
ES2232687T3 (es) 2005-06-01
CA2288003C (en) 2003-10-21
LV12492B (en) 2001-01-20
DE69827417T2 (de) 2005-10-27
WO1998050035A1 (en) 1998-11-12
NZ513881A (en) 2002-10-25
EE04870B1 (et) 2007-08-15
EA200100956A1 (ru) 2002-02-28
NO995406L (no) 2000-01-04
EP1005342B1 (en) 2002-12-04
IL132516A (en) 2003-12-10
ES2150404T1 (es) 2000-12-01
IL132516A0 (en) 2001-03-19
RO120605B1 (ro) 2006-05-30
HUP0003330A2 (hu) 2001-05-28
IS5223A (is) 1999-10-19
CN1158074C (zh) 2004-07-21
JP3739802B2 (ja) 2006-01-25
ATE228839T1 (de) 2002-12-15
IS2087B (is) 2006-03-15
AR057242A2 (es) 2007-11-21
KR20010020322A (ko) 2001-03-15
BG103958A (en) 2000-07-31
HUP0003330A3 (en) 2002-10-28
NO313983B1 (no) 2003-01-13
HU229641B1 (en) 2014-03-28
EA002908B1 (ru) 2002-10-31
EP1005342A1 (en) 2000-06-07
EE9900578A (et) 2000-08-15
LV12492A (en) 2000-06-20
PL336805A1 (en) 2000-07-17
PL193275B1 (pl) 2007-01-31
ATE281166T1 (de) 2004-11-15
DK1222921T3 (da) 2005-03-07

Similar Documents

Publication Publication Date Title
RS50158B (sr) Celekoksibne smeše
NO20004980D0 (no) Partikulær virkestoffbærer for pulmonær anvendelse
SE9200951D0 (sv) Pharmaceutical composition containing a defined lipid system
RS49831B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
ATE242783T1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
CO4920201A1 (es) Composiciones acondicionadoras del cabello en champu que contienen surfactante, alcohol graso y particulas de agente acondicionador
RS49611B (sr) Ziprasidon formulacije
YU45915B (sh) Osnovna smesa za nosač terapeutski aktivnog medikamenta
FI953442A (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
BR9916132A (pt) Composições e utilização das mesmas
DE69305328D1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
ME00530B (me) Farmaceutske kompozicije tizoksanida i nitazoksanida
BR9608208A (pt) Composição de revestimento de pó para revestimento eletrotático de substrato farmacêuticos
KR870003781A (ko) 지효성 조성물
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
DK1124544T3 (da) Tørpulverformig, farmaceutisk formulering
RS50345B (sr) Vodena farmaceutska kompozicija koja sadrži ciklesonid
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
YU7196A (sh) Farmaceutska formulacija koja sadrži kombinaciju foskarneta i jednog protivzapaljenskog glukokortikoida
GEP20022840B (en) Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment
CU22990A3 (es) Composiciones farmacéuticas de la tizoxanida y la nitazoxadina
IT1270976B (it) Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono